Trial Profile
Apatinib as Adjuvant Treatment in the Recurrence of Hepatocellular Carcinoma
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2016
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 08 Nov 2016 New trial record